How have ESLAW shares performed this year?

Estrella Immunopharma's stock was trading at $0.03 at the start of the year. Since then, ESLAW stock has increased by 233.3% and is now trading at $0.10. View the best growth stocks for 2024 here .

How do I buy shares of Estrella Immunopharma?

Shares of ESLAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ESLAW

Estrella Immunopharma (ESLAW) Stock Price, News & Analysis

$0.10

0.00 (0.00%)

(As of 09/6/2024 ET)

Compare

Today's Range: $0.10
▼
$0.10
50-Day Range: $0.04
▼
$0.11
52-Week Range: $0.03
▼
$0.34

Volume: N/A
Average Volume: 4,940 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Trends

Get Estrella Immunopharma alerts:

Ad Golden Crest

Biden’s Capital Gains Tax to Devastate Savings!

Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.

>> Get Your FREE Wealth Protection Guide <<

About Estrella Immunopharma

Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.

ESLAW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ESLAW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive ESLAW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:ESLAW
CUSIP: N/A
CIK: 1844417
Web: www.estrellabio.com
Phone: 510-318-9098
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Dr. Cheng Liu Ph.D. (Age 57)
CEO, President & Director
Mr. Jiandong Xu (Age 53)
Chief Financial Officer

Key Competitors

View All Competitors

ESLAW Stock Analysis - Frequently Asked Questions

How have ESLAW shares performed this year?: Estrella Immunopharma's stock was trading at $0.03 at the start of the year. Since then, ESLAW stock has increased by 233.3% and is now trading at $0.10.
View the best growth stocks for 2024 here.
How do I buy shares of Estrella Immunopharma?: Shares of ESLAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.